Learn more

MOLECULAR TEMPLATES INC

Overview
  • Total Patents
    185
  • GoodIP Patent Rank
    8,252
  • Filing trend
    ⇧ 21.0%
About

MOLECULAR TEMPLATES INC has a total of 185 patent applications. It increased the IP activity by 21.0%. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are TALIGEN THERAPEUTICS INC, DOMANTIS LTD and COVAGEN AG.

Patent filings per year

Chart showing MOLECULAR TEMPLATES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Willert Erin 135
#2 Poma Eric 133
#3 Kim Jason 70
#4 Higgins Jack 56
#5 Rajagopalan Sangeetha 37
#6 Brieschke Brigitte 31
#7 Robinson Garrett Lee 31
#8 Eric Poma 20
#9 Erin Willert 20
#10 Jason Kim 11

Latest patents

Publication Filing date Title
US2021079098A1 Pd-l1-binding molecules comprising shiga toxin a subunit scaffolds
US2021079097A1 Pd-l1-binding molecules comprising shiga toxin a subunit scaffolds
WO2020154475A1 Proteins comprising modified immunoglobulin variable light chains
GB201914920D0 Light chain kappatization of molecules comprising immunoglobulin domains
WO2020081493A1 Pd-l1 binding proteins
AU2019257343A1 HER2-targeting molecules comprising de-immunized, Shiga toxin A Subunit scaffolds
AU2018213194A1 Cell-targeting molecules comprising de-immunized, Shiga toxin A Subunit effectors and CD8+ T-cell epitopes
AU2017373962A1 Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
US2017275382A1 Multivalent cd20-binding molecule comprising shiga toxin a subunit effector polypeptides and enriched compositions therefof
CA2991259A1 Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
US2018243432A1 Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
US2018258143A1 De-Immunized, Shiga Toxin A Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same
KR20170110601A Multivalent CD20 binding molecules comprising a < RTI ID = 0.0 > cigarotoxin A < / RTI >
US2016177284A1 Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions
US2017210769A1 TH-302 solid forms and methods related thereto
WO2015191764A1 Protease-cleavage resistant, shiga toxin a subunit effector polypeptides and cell-targeted molecules comprising the same
EP3116905A1 Proteins comprising binding regions, shiga toxin a subunit effector regions, and carboxy-terminal, endoplasmic reticulum localization signal motifs
US2015259428A1 Cd20-binding proteins comprising shiga toxin a subunit effector regions for inducing cellular internalization and methods using same
EP3604333A1 Proteins comprising amino-terminal proximal shiga toxin a subunit effector regions and cell-targeting immunoglobulin-type binding regions capable of specifically binding cd38
CA2937524A1 Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity